OCT 25, 2016 8:22 AM PDT

Surprising Gene Mutation Reveals Rare Immunodeficiency

WRITTEN BY: Kara Marker
Next-generation sequencing revealed a rare protein deficiency from an inherited genetic mutation as the cause of a severe immune disease. Until now, the gene’s role in the human immune system was unknown.
The image shows RASGRP1-dependent vesicle transport towards the immunological synapse. Image Credit: CeMM/Tatjana Hirschmugl
One 12-year-old patient is the only affected child in their family, after three of the patient’s siblings died within the first two years of life from a mysterious diseases. Beginning immediately after birth, the patient experienced serious, potentially lethal infections that his immune system couldn’t control. After examination, scientists realized he lacked the lymphocytes for the immune system to successfully mount an attack against infection.

Knowing that three siblings experienced the same disease in addition to the 12-year-old, a collaborative researcher team from CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases and the Medical University at Vienna suggested a heritable genetic trait was the cause of all four conditions. Next-generation genomic sequencing confirmed their theory.

"Our analyses of the patient's and his parents' genomes indeed confirmed that the boy's disorder had a genetic cause," explained the study’s first author, CeMM’s Elisabeth Salzer.

They found that a mutation in the gene encoding a protein called RASGPR1 was at the root of the disease; RASGPR1 is vital in the development of lymphocytes. However, the study also showed that the protein also plays role in the maintenance of the cytoskeleton, the backbone of the cell, in natural killer cells; the details of how the protein affects these lymphocytes is still unknown.

The researchers also showed that, as expected, the healthy parents and healthy siblings had just one copy of the mutation, while the affected 12-year-old had two faulty copies; clearly one mutated copy was not enough to cause the recessive disease.
Senior author Kaan Boztug and first author Elisabeth Salzer. Image Credit: CeMM/Wolfgang Däuble
Until now, RASGPR1’s role in the human immune system was unknown; a mutation that inhibited the protein had never before been reported.

The research team has already made progress in developing treatments for this disease. An FDA-approved drug called lenalidomide has been shown to reverse some of the effects caused by RASGRP1 deficiency. There’s still a long way to go, and scientists are now looking at the possibility of using gene therapy to treat the disease.

This study was recently published in the journal Nature Immunology.
 


Source: CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 21, 2021
Immunology
Sunshine Vitamin Boosts Dairy Cows' Immunity
OCT 21, 2021
Sunshine Vitamin Boosts Dairy Cows' Immunity
A new study shows how vitamin D can help dairy cows fend off infections, offering opportunities for better animal health ...
NOV 01, 2021
Cell & Molecular Biology
How SARS-CoV-2 Evades Antiviral Defenses
NOV 01, 2021
How SARS-CoV-2 Evades Antiviral Defenses
Researchers have learned a lot about the SARS-CoV-2 virus since the start of the COVID-19 pandemic. We know that he viru ...
NOV 05, 2021
Cancer
The Labroots 2021 Cancer Research and Oncology Virtual Event Poster Winner
NOV 05, 2021
The Labroots 2021 Cancer Research and Oncology Virtual Event Poster Winner
Every year, Labroots hosts an exciting series of Virtual Events that focus on various scientific topics. These virtual m ...
JAN 04, 2022
Immunology
Scientists Win a Game of Bacterial Hide-And-Seek
JAN 04, 2022
Scientists Win a Game of Bacterial Hide-And-Seek
When infection strikes, antibiotics are the go-to solution to help patients regain control from the invading bacter ...
JAN 07, 2022
Cancer
Crossing the Blood-Brain Barrier: Improving Experimental Models to Study Drug Delivery
JAN 07, 2022
Crossing the Blood-Brain Barrier: Improving Experimental Models to Study Drug Delivery
The blood-brain barrier (BBB) describes the complex vasculature network that delivers oxygen and nutrients to the brain. ...
JAN 07, 2022
Health & Medicine
Israel Approves Fourth Dose of COVID-19 Vaccine
JAN 07, 2022
Israel Approves Fourth Dose of COVID-19 Vaccine
While third doses are being approved for adults in countries worldwide, Israeli citizens are already receiving a fourth. ...
Loading Comments...